baber/WOPTO huggingface dataset:
Patent NZ-576528-A (NZ)
Title: A pneumatically pressurised reservoir for a beverage machine using cartridges
Inventor: BRUDEVOLD FINN
IPC: A47J31/32
Filed: 2007-09-07
Abstract: A beverage formation device and method for its use is disclosed. The device uses pneumatic pressure to force heated liquid through a cartridge to for the beverage. It contains a brew chamber (1) for receiving a beverage cartridge and has a lid to enclose the cartridge when forming the beverage. A reservoir (5) holds a beverage precursor liquid, such as water, and also has a lid that covers an access opening through which the liquid poured into the reservoir (5). The reservoir lid seals the reservoir (5) so that pressure may be built up when the lid is in a closed position, the lid being closed by the user by hand. A heater (94) heats the liquid as it is pushed by pressure though to the cartridge. (62) Divided Out of 575941
Patent NZ-579082-A (NZ)
Title: Stable suspensions of micronised particles of a solid organic compound which is free of surfactants, thickeners, poly-electrolytes or block copolymers
Inventor: HEE VAN PIM
IPC: A61K9/10
Filed: 2008-03-14
Abstract: Disclosed is a method for preparing a stable suspension of micronised particles of a solid organic compound (including representative compounds such as natamycin, nystatin, cocoa, coffee etc.), the method comprising the steps of: a) i) subjecting the solid organic compound to wet grinding at distinct pH values to provide suspensions of micronised particles of the solid organic compound each having a distinct pH value; or ii) subjecting the solid organic compound to wet grinding at one pH value and adjusting the pH of the resultant suspension after grinding to provide suspensions of micronised particles of the solid organic compound each having a distinct pH value; b) determining which of the obtained suspensions is stable; and c) preparing a stable suspension of micronised particles, as determined by step b), by means of wet grinding; wherein the suspension is free of surfactants, thickeners, poly-electrolytes or block copolymers; wherein a stable suspension is determined as having a mean particle size, over a period of at least 1 day after size reduction, that does not increase more than a factor 10. Also disclosed is a stable suspension and / or concentrated suspension of micronised particles obtained by the above method, and which may be used in the form of a paste, powder, film, coating or foil in the food or feed industry, in horticulture, in agriculture or in the pharmaceutical industry.
Patent NZ-579796-A (NZ)
Title: Microbicidal composition N-methyl-1,2-benzisothiazolin-3-one and 2,2-dibromo-3-nitrilopropionamide
Inventor: ASHMORE JOHN WILLIAM
IPC: A01N31/02
Filed: 2008-06-03
Abstract: Disclosed is a microbicidal composition comprising: (a) N-methyl-l,2-benzisothiazolin-3-one; and (b) 2,2-dibromo-3-nitrilopropionamide; wherein the ratio of2,2-dibromo-3-nitrilopropionamide to N-methyl-l,2benzisothiazolin-3-one is as disclosed in the specification. (62) Divided Out of 568775
Patent NZ-585000-A (NZ)
Title: New antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs
Inventor: VANMECHELEN EUGEEN
IPC: C07K16/18
Filed: 2008-10-24
Abstract: A monoclonal antibody that binds to the N-terminal region of Amyloid beta8-x peptide, wherein x equals amino acids residues 15-42. The antibody does not bind to Amyloid beta1-40 nor to Amyloid beta 1-42. The antibody specifically targets the parenchymal amyloid deposits of Amyloid beta 8-x in the brain and does not interact with vascular amyloid deposits. The antibodies can be used in methods for determining amyloid burden in a mammal and also for determining the susceptibility of a mammal to a disease associated with beta-amyloid formation and aggregation, such as Alzheimer's disease.
Patent NZ-585729-A (NZ)
Title: Heterocyclic derivatives as modulators of ion channels
Inventor: STAMOS DEAN
IPC: A61K31/4427
Filed: 2008-11-12
Abstract: Disclosed is a compound of formula (I) where the substituents are as disclosed in the specification and examples of compounds of formula (I) are (S)-4-(3-( 6,7-dichloro-3,4-dihydroisoquinolin-2(1H)-yl)-2-oxopyrrolidin-1-yl)-N-(thiazol-2-yl)benzenesulfonamide and (S)-4-(2-oxo-3-(7-( trifluoromethyl)-3,4-dihydroisoquinolin-2(1H)yl)pyrrolidin-1-yl)-N-(thiazol-2-yl)benzenesulfonamide. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for treating conditions such as arthritis, migraines, pain and epilepsy.
Patent NZ-586091-A (NZ)
Title: Pharmaceutical compositions of rhein or diacerein
Inventor: DABRE RAHUL
IPC: A61P19/02
Filed: 2008-09-16
Abstract: Disclosed is a melt granulated pharmaceutical composition comprising 20mg to 45mg of rhein or diacerein, or salts or esters thereof and one or more pharmaceutically acceptable carriers. Processes for making the pharmaceutical composition are also disclosed.
Patent NZ-586997-A (NZ)
Title: Needle cover membrane for assisting sterile connection to another medical device
Inventor: GYRN STEFFEN
IPC: A61M5/158
Filed: 2009-02-24
Abstract: A device with a self-supporting membrane covering or surrounding or encompassing a hollow hypodermic needle to maintain a sterile environment for the transfer of fluid or liquid or gas, that allows multiple clean connections to other sterile medical devices or tubes by piercing, penetrating or puncturing the membrane. The membrane is fixed at its open end and tapers down to a reduced cross-section at the protruding end. The wall thickness at the free end is increased over that of the attached end to reduce the internal air volume. The inner walls of the membrane can be supported by the needle. The device also contains base, a method of fastening the device to a subject and a projection that allows the membrane to form a tight mechanical interference friction fit.
Patent NZ-593377-A (NZ)
Title: Crystalline forms of a 3-carboxypropyl-aminotetralin compound
Inventor: DALZIEL SEAN
IPC: C07C231/24
Filed: 2009-12-09
Abstract: Disclosed herein is a crystalline solid form of (S)-4-((2S,3S)-7-carbamoyl-1,1-diethyl-3-methoxy-1,2,3,4-tetrahydronaphthalen-2-ylamino)-2-cyclohexylmethyl-butyric acid (compound of formula I) or a crystalline hydrochloride salt of (S)-4-((2S,3S)-7-carbamoyl-1,1-diethyl-3-methoxy-1,2,3,4-tetrahydronaphthalen-2-ylamino)-2-cyclohexylmethyl-butyric acid, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as mu opioid receptor antagonists and as such are useful for treating or ameliorating medical conditions such as opioid-induced bowel dysfunction or post-operative ileus, a disorder of reduced motility of the gastrointestinal tract, side effects associated with use of an opioid agent in a mammal.
Patent NZ-594113-A (NZ)
Title: Gravity power generating apparatus
Inventor: YEH HUNG HSIEN
IPC: F03G3/02
Filed: 2011-07-15
Abstract: Disclosed is a gravity-based power generating apparatus (1). The apparatus (1) is comprised of a plurality of magnetised heavy objects (102) as a set of heavy objects, a generator (106) having a rotor, a delivery route chain, a delivery route motor (103) and a plurality of magnetic elements (104). The generator (106) is for generating electrical power by rotation of its rotor. The rotation of the generator (106) is intended to be accomplished by having each heavy object (102) of the set of heavy objects to pass through a gravity route (1021) under the influence of gravity. The delivery route chain is for delivering each heavy object (102) from a lowest level spot (A) in the delivery route (101) to a highest level spot (B) in the delivery route (101) to drive each heavy object (102) to pass through the gravity route (1021) under the influence of gravity. The delivery route motor (103) is for supplying power for the delivery route (101). The magnetic elements (104) are provided around the gravity route (1021). Each magnetic element (104) has a coil (105) wound around its surface so that the changing magnetic flux occurring when each heavy object (102) passes through the gravity route (1021) induces an electrical current in the coil (105) due to electromagnetic induction. This current is intended to supply energy to the delivery route motor (103). The gravity route (1021) is provided with a gravity transmission chain (1023) which engages with each heavy object (102) to be pulled by each heavy object (102) as it moves downwards under the influence of gravity and consequently to rotate the rotor of the generator (106).
Patent NZ-596388-A (NZ)
Title: Thiazole derivatives and their use as p2y12 receptor antagonists
Inventor: CAROFF EVA
IPC: A61K31/426
Filed: 2010-04-21
Abstract: Disclosed herein are thiazole- piperazine compound of formula (I), wherein W represents a thiazole group selected from (G1) or (G2), with the other substituents as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as P2Y12 receptor antagonists and as such are useful in the treatment and/or prevention of peripheral vascular, or visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
Patent NZ-597122-A (NZ)
Title: Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
Inventor: BUR DANIEL
IPC: C07C233/58
Filed: 2010-05-17
Abstract: The present invention relates to bridged spiro[2.4]heptane derivatives of formula (I), wherein W, Y, Z, R1 and R2 are as defined in the description, their preparation and their use as pharmaceutically active compounds as ALX receptor and/or FPRL2 agonists for the treatment of inflammatory and obstructive airways diseases. These compounds and there pharmaceutically acceptable salts are suitable for the treatment of inflammatory diseases, obstructive airway diseases, allergic conditions, HIV-mediated retroviral infections, cardiovascular disorders, neuroinflammation, neurological disorders, pain, prion-mediated diseases and amyloid-mediated disorders; and for the modulation of immune responses.
Patent NZ-597263-A (NZ)
Title: Agricultural or horticultural fungicide composition of cyazofamid and folpet and its use for controlling plant pathogens
Inventor: SUGIMOTO KOJI
IPC: A01P3/00
Filed: 2010-07-06
Abstract: The present disclosure provides a composition in which a fungicidal effect against a cultivated crop infected by a plant pathogen is stable and highly active. An excellent agricultural or horticultural fungicide composition for controlling a plant pathogen is provided by using (a) cyazofamid and (b) folpet as active ingredients; by combination as compared to a single use of each compound, and a plant pathogen is thereby controlled.
Patent NZ-602292-A (NZ)
Title: Spirocyclic compounds and their use as therapeutic agents and diagnostic probes
Inventor: GIESE BERND
IPC: A61K31/5386
Filed: 2011-03-11
Abstract: The disclosure relates to compounds represented by formula (I) carrying a spirocyclic substituent, which include triazines (G = Q = U are N), pyrimidines (two out of G, Q and U are N), and pyridopyrimidines (one of G and U together with R2 forms an anullated pyridine ring), wherein E1 is CR4 or N; X1 is CHR4, CH2CH2, NR4, NR4O, or O; and the other substituents are as defined in the specification. These compounds inhibit phosphoinositide 3-kinase (PBK), mammalian target of rapamycin (mTOR), DNA-PK and ATM kinase, and may be used as therapeutic agents or diagnostic probes. The disclosure also relates to methods of using the compounds for treatment of associated pathological conditions particularly hyperproliferative disorders.
Patent NZ-609057-A (NZ)
Title: Furniture member powered headrest rotation and release system
Inventor: LAPOINTE LARRY P
IPC: A47C1/02
Filed: 2011-08-11
Abstract: A powered headrest operating system for a chair is disclosed. The system comprises a headrest frame assembly (58) rotatably connected to a seatback frame (16) and an actuation mechanism (90) connected to the seatback frame and to the headrest frame to rotate the headrest from a fully retracted to a fully forward position. A spring member (76) is connected to the seatback frame (16) and the headrest frame (58) creating a biasing force during rotation of the headrest away from the retracted position. The system may further include a release system (Fig. 12) permitting the headrest frame assembly to be retained at a forward position while the actuation mechanism (90) returns to the retracted position. The release mechanism allows the actuator (90) to return to the retracted position if an obstruction blocks return of the headrest (58).
Patent NZ-609509-A (NZ)
Title: Releasably closable product accommodating package
Inventor: CLARK KERRI
IPC: B65D85/10
Filed: 2011-10-27
Abstract: Disclosed is a package assembly for accommodating and dispensing a plurality of elongate consumable products such as chewing gum. The package permits the consumer to repeatedly open and close the package by using a releasable closure mechanism. The package assembly comprises package housing for supporting the products. The package housing includes a first product accommodating compartment (312) and a second product accommodating compartment (314) separated by a hinge (355). Each product accommodating compartment (312, 314) has an open end adjacent the hinge (355). The compartments (312, 314) are foldable about the hinge (255). A releasable closure is disposed on each compartment (312, 314) and positioned to be in aligned facing relationship for mutual engagement upon closably folding the compartments (312, 314) about the hinge (355). The releasable closure is selected from the group consisting of a clip, mating hook and loop fasteners, magnetic fasteners (360, 362), pressure sensitive labels, static cling film, pressure sensitive adhesives and interfitting mechanical devices.
Patent NZ-619147-A (NZ)
Title: Methods, apparatuses, and systems for driving a movable partition with a lead drive box
Inventor: SMART R SCOTT
IPC: E05F15/56
Filed: 2012-06-21
Abstract: Disclosed are movable partition systems including a movable partition engaged with and movable along a longitudinal track and a lead drive box coupled to the movable partition and engaged with the track. The lead drive box is configured to move along the track and move the movable partition along the track. The lead drive box includes a trolley for disposition within the track, a motor coupled to the lead drive box, and a rotatable drive member coupled to the lead drive box and the motor. The rotatable drive member engages an elongated drive member extending along the track to motivate the lead drive box and the movable partition attached thereto along the track when engaged with the motor and the motor is rotating. An electronics module disposed within the lead drive box is configured for controlling operation of the motor responsive to signals originating from sources carried by the lead drive box. Electrical components of the electronics module are offset from each other in a vertical direction within the lead drive box.
Patent NZ-627432-A (NZ)
Title: A method of forming a gypsum based product
Inventor: MONGROLLE JEAN-LOUIS
IPC: C04B28/14
Filed: 2012-12-13
Abstract: A method of forming a gypsum based product is disclosed. The method comprises the steps of: calcining a mixture of water and gypsum under conditions of raised temperature and pressure within a vessel to produce an alpha-hemihydrate slurry therein; passing the alpha-hemihydrate slurry from the vessel to a mixer for mixing with additional water to produce a settable slurry, which is arranged to set to form the gypsum based product.
Patent NZ-631034-A (NZ)
Title: Targeting aminoacid lipids
Inventor: PLATSCHER MICHAEL WILHELM
IPC: C07K7/64
Filed: 2013-03-11
Abstract: The present disclosure is directed to carrier systems comprising ether-lipids conjugated to one or more bioactive ligands and exposed on the surface of the carrier system for use in targeted delivery and/or antigen display systems. Optionally one or more further bioactive agents may be encapsulated or embedded within or attached to or adsorbed onto the carrier system. The present disclosure is further directed to methods of their preparation and their uses in medical applications, such as targeted delivery of bioactive agents to specific tissues or cells and antigen display systems for the study, diagnosis, and treatment of traits, diseases and conditions that respond to said bioactive agents.
Patent NZ-703411-A (NZ)
Title: Use of markers in the diagnosis and treatment of prostate cancer
Inventor: NARAIN NIVEN RAJIN
IPC: G01N33/68
Filed: 2013-06-27
Abstract: The invention provides method for diagnosis, monitoring, and prognosis of prostate cancer using one or more prostate cancer related markers comprising keratin 19. The invention provides kits for practicing the methods of the invention.
Patent NZ-705634-A (NZ)
Title: Interactive heating and cooking apparatus and disposable tray system therefore
Inventor: HEONG MENG YUEN
IPC: F24C15/06
Filed: 2013-12-12
Abstract: An expandable disposable drip tray including concertina like channel shaped structure (27) with end formations (29) located across at least a lower portion of each end of the channel shaped structure to prevent leakage from the tray during use. The channel shaped structure has a base portion with spaced apart sides extending upwardly from edges of the base portion, wherein said base portion and sides of the channel shaped structure are configured to progressively expand or contract in a concertina like manner via a series of interconnected folds to vary the size of the tray along the longitudinal axis of the channel. The drip tray may include a mesh element (26), supported by the tray element, for cooking food thereon.
Patent NZ-706833-A (NZ)
Title: Thin web optical media guiding method
Inventor: JANSSEN CLARK M
IPC: G11B15/67
Filed: 2013-11-07
Abstract: Typically, data storage tape tends to move in undesired directions, limiting its storage density. Disclosed is an improved optical data storage device (10) including an optical storage tape (12) having one or more optical storage layers. A plurality of optical pickup units (14) reads and/or writes data to the optical storage tape (12). A feed reel (16) provides the optical storage tape (12) to the optical pickup units (14). A guiding wheel (20) guides the optical storage tape (12) when the optical storage tape (12) is in the vicinity of the optical pickup units (14) during read and/or write operations. The guiding wheel (20) holds the optical storage tape (12) on a circular path during read/write/tracking operations. Finally, a take-up reel (22) receives the optical storage tape (12) from the guiding wheel.
Patent NZ-709097-A (NZ)
Title: Method and system for hub breakout roaming
Inventor: XU RICHARD
IPC: H04W8/08
Filed: 2013-12-04
Abstract: A method of handling roaming services for mobile devices, the method including receiving, at a hub breakout system, a request for data access associated with a user network device roaming in a visited communications network, the user network device being subscribed to a home communications network, assigning, by the hub breakout system, an internet protocol (IP) address to the user network device, and routing, by the hub breakout system, data packets, associated with the data access requested by the user network device, to and from at least one corresponding data source using the assigned IP address, wherein both the home communications network and the visited communications network are independent and separate of the hub breakout system. This enables provision of data access to the user network device, subscribed with the home network and roaming into the visited network, by the hub breakout system through the visited network.
Patent NZ-713040-A (NZ)
Title: Applicator head for applying material to a user’s skin
Inventor: DEBNATH GAUTAM
IPC: B65D47/42
Filed: 2014-04-16
Abstract: The invention relates to applicator heads for applying a fluid material to a user’s skin. Dispensing containers are known, but these are not optimised for dispensing fluid material to a user’s skin. Thus, the invention provides an applicator head for a fluid material comprising: a neck part having a flow conduit for the flow of the fluid material in a flow direction between an inlet end of the conduit and an outlet end of the conduit; an outlet part comprising a skirt wall descending from an end wall and comprising a sleeve externally mounted on the neck part and being reciprocally slideably moveable on the neck part between a first position and a second position, the outlet part having an outlet opening through which fluid material may flow, the neck part incorporating a closure part which when the outlet part is in the first position is engaged with the outlet opening to close flow of the fluid material from the flow conduit through the outlet opening, and when the outlet part is in the second position is disengaged from the outlet opening to allow flow of the fluid material from the flow conduit through the outlet opening, wherein the outlet part has an external applicator surface comprising a generally flat external surface of the end wall adapted to apply the fluid material to a user’s skin and the outlet opening is an opening through the applicator surface, and; wherein the outlet conduit has a bi-frustroconical internal profile tapering inwardly from its upstream and downstream ends towards a narrow point between these two ends, with the closure part having a surface profile corresponding to the narrowing of the outlet conduit towards the outlet end to sealingly mate with the outlet conduit, and where the closure part fits into the upstream end of the outlet conduit.
Patent NZ-728131-A (NZ)
Title: Aqueous ophthalmic composition
Inventor: SONOKE SHIROU
IPC: A61P27/02
Filed: 2015-07-10
Abstract: The present invention is intended to solve problems of ophthalmic composition suspensions that often result in eye irritation and blurred vision because of insufficient particle micronization. The present invention therefore provides for an aqueous ophthalmic composition comprising: a carbonic anhydrase inhibitor selected from at least one of: brinzolamide and a salt thereof; at least one cellulose derivative selected from the group consisting of: hydroxypropylmethyl cellulose acetate succinate and carboxymethylethyl cellulose; and water.
Patent NZ-731483-A (NZ)
Title: A novel wearable vibration device
Inventor: LEFTLY STEVEN
IPC: A61H23/02
Filed: 2015-10-06
Abstract: The present invention provides a novel wearable vibration device. According to an embodiment, the novel wearable vibration device delivering high energy vibration deep in to the muscles and soft tissues for muscle treatment comprising an upper soft fabric foam covered case encompassing at least a vibration motor, a lithium ion battery, a control PCB, a control switch with LED display and a lower fabric covered case. The wearable vibration device delivers high energy vibration to the chosen muscle group and thereby, penetrates deep in to the muscle and to the soft tissues. The upper soft fabric foam covered case and lower fabric covered cases are fixed together by gluing or stitching. The control PCB drives vibration motor to set frequencies for vibration motor activations. Vibrations for the device are tuned at frequencies in the range of 30-50Hz to increase muscle power and for other beneficial physiological effects.